{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:31:28Z","timestamp":1791070288180,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.lungcan.2008.08.014","type":"journal-article","created":{"date-parts":[[2008,10,5]],"date-time":"2008-10-05T08:06:25Z","timestamp":1223193985000},"page":"140-147","source":"Crossref","is-referenced-by-count":132,"title":["Functional inactivation of NF2\/merlin in human mesothelioma"],"prefix":"10.1016","volume":"64","author":[{"given":"Claudio","family":"Thurneysen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Weder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf A.","family":"Stahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Felley-Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2008.08.014_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30227","article-title":"The pathogenesis of mesothelioma","volume":"29","author":"Carbone","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lungcan.2008.08.014_bib2","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","article-title":"High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas","volume":"92","author":"Bianchi","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lungcan.2008.08.014_bib3","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Sekido","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2008.08.014_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6","article-title":"Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene","volume":"77","author":"Deguen","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib5","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1038\/sj.onc.1209587","article-title":"Re-expression of the tumor suppressor NF2\/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK","volume":"25","author":"Poulikakos","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2008.08.014_bib6","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1038\/sj.onc.1206593","article-title":"Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours","volume":"22","author":"Fleury-Feith","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2008.08.014_bib7","doi-asserted-by":"crossref","DOI":"10.4161\/cc.4.12.2300","article-title":"Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma","volume":"4","author":"Lecomte","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lungcan.2008.08.014_bib8","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/jnci\/87.24.1870","article-title":"Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma","volume":"87","author":"Kratzke","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2008.08.014_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jnci\/92.8.636","article-title":"Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells","volume":"92","author":"Yang","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2008.08.014_bib10","first-page":"5547","article-title":"p16 alterations and deletion mapping of 9p21\u2013p22 in malignant mesothelioma","volume":"54","author":"Cheng","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2008.08.014_bib11","first-page":"511","article-title":"Codeletion of p15 and p16 in primary malignant mesothelioma","volume":"11","author":"Xio","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2008.08.014_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<649::AID-IJC25>3.0.CO;2-2","article-title":"The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma","volume":"75","author":"Prins","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib13","first-page":"5727","article-title":"Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma","volume":"61","author":"Toyooka","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2008.08.014_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0169-5002(02)00178-2","article-title":"Inactivation of p16INK4a expression in malignant mesothelioma by methylation","volume":"38","author":"Wong","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2007.08.035","article-title":"Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient\u2019s follow-up","volume":"59","author":"Destro","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccr.2008.01.030","article-title":"A conditional mouse model for malignant mesothelioma","volume":"13","author":"Jongsma","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2008.08.014_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/geno.2001.6672","article-title":"Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts","volume":"79","author":"Chang","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.lungcan.2008.08.014_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/3.4.565","article-title":"Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers","volume":"3","author":"Arakawa","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lungcan.2008.08.014_bib19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/hmg\/3.4.559","article-title":"The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts","volume":"3","author":"Pykett","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lungcan.2008.08.014_bib20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/8.8.1561","article-title":"Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules","volume":"8","author":"Schmucker","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lungcan.2008.08.014_bib21","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product","volume":"15","author":"Sherman","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2008.08.014_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/hmg\/7.3.335","article-title":"Defects in neurofibromatosis 2 protein function can arise at multiple levels","volume":"7","author":"Gutmann","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lungcan.2008.08.014_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1101\/gad.13.8.978","article-title":"Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein","volume":"13","author":"Giovannini","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.lungcan.2008.08.014_bib24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ncb1641","article-title":"Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation","volume":"9","author":"Tang","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.lungcan.2008.08.014_bib25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejcts.2007.09.045","article-title":"PTEN expression is a strong predictor of survival in mesothelioma patients","volume":"33","author":"Opitz","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.lungcan.2008.08.014_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tcb.2007.03.006","article-title":"Shedding light on Merlin\u2019s wizardry","volume":"17","author":"Okada","year":"2007","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.lungcan.2008.08.014_bib27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature04856","article-title":"Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase","volume":"442","author":"Jin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2008.08.014_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2","article-title":"Frequency and distribution of NF2 mutations in schwannomas","volume":"17","author":"Jacoby","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0014-5793(03)00576-3","article-title":"Heme oxygenase-1 induction by endogenous nitric oxide: influence of intracellular glutathione","volume":"546","author":"Andre","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.lungcan.2008.08.014_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1593\/neo.06148","article-title":"p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma","volume":"8","author":"Hopkins-Donaldson","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.lungcan.2008.08.014_bib31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1476-4598-6-66","article-title":"Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin","volume":"6","author":"Belyanskaya","year":"2007","journal-title":"Mol Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(83)90155-1","article-title":"Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture","volume":"34","author":"Connell","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2008.08.014_bib33","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.5858\/2005-129-1407-IDOEMA","article-title":"Immunohistochemical diagnosis of epithelioid mesothelioma: an update","volume":"129","author":"Ordonez","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.lungcan.2008.08.014_bib34","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1158\/1078-0432.CCR-05-0578","article-title":"New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA","volume":"11","author":"Onda","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2008.08.014_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ijc.2910510220","article-title":"Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature","volume":"51","author":"Schmitter","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib36","first-page":"979","article-title":"Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma","volume":"134","author":"Ke","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lungcan.2008.08.014_bib37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mrfmmm.2007.07.015","article-title":"Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity","volume":"637","author":"Lepont","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.lungcan.2008.08.014_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1470-2045(07)70104-3","article-title":"Alternative splicing: an emerging topic in molecular and clinical oncology","volume":"8","author":"Pajares","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2008.08.014_bib39","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/oxfordjournals.jbchem.a124664","article-title":"An exon 8-spliced out transcript of neurofibromatosis 2 gene is constitutively expressed in various human tissues","volume":"116","author":"Hitotsumatsu","year":"1994","journal-title":"J Biochem"},{"key":"10.1016\/j.lungcan.2008.08.014_bib40","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.onc.1202010","article-title":"Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain","volume":"17","author":"Koga","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2008.08.014_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/hmg\/3.3.413","article-title":"Exon scanning for mutation of the NF2 gene in schwannomas","volume":"3","author":"Jacoby","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lungcan.2008.08.014_bib42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<238::AID-GCC9>3.0.CO;2-M","article-title":"Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation","volume":"24","author":"Cheng","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib43","doi-asserted-by":"crossref","first-page":"18559","DOI":"10.1074\/jbc.M313916200","article-title":"Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization","volume":"279","author":"Alfthan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2008.08.014_bib44","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44","volume":"15","author":"Morrison","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.lungcan.2008.08.014_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","article-title":"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling","volume":"1","author":"Shaw","year":"2001","journal-title":"Dev Cell"},{"key":"10.1016\/j.lungcan.2008.08.014_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/386761a0","article-title":"Cancer-susceptibility genes. Gatekeepers and caretakers","volume":"386","author":"Kinzler","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2008.08.014_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.bjc.6604002","article-title":"Nf2\/Merlin: a coordinator of receptor signalling and intercellular contact","volume":"98","author":"Curto","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib48","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200703010","article-title":"Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin","volume":"177","author":"Curto","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.lungcan.2008.08.014_bib49","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1073\/pnas.0700044104","article-title":"The Nf2 tumor suppressor regulates cell\u2013cell adhesion during tissue fusion","volume":"104","author":"McLaughlin","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lungcan.2008.08.014_bib50","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1074\/jbc.M200083200","article-title":"Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization","volume":"277","author":"Kissil","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2008.08.014_bib51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1892","article-title":"p21-Activated kinases in cancer","volume":"6","author":"Kumar","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lungcan.2008.08.014_bib52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1074\/jbc.C100553200","article-title":"p21-Activated kinase links Rac\/Cdc42 signaling to merlin","volume":"277","author":"Xiao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2008.08.014_bib53","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1098\/rstb.2004.1466","article-title":"Wound healing and inflammation: embryos reveal the way to perfect repair","volume":"359","author":"Redd","year":"2004","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.lungcan.2008.08.014_bib54","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1097-2765(03)00382-4","article-title":"Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1","volume":"12","author":"Kissil","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.lungcan.2008.08.014_bib55","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00023.2003","article-title":"Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase","volume":"83","author":"Somlyo","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.lungcan.2008.08.014_bib56","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1073\/pnas.88.20.9307","article-title":"G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle","volume":"88","author":"Kitazawa","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lungcan.2008.08.014_bib57","first-page":"3101","article-title":"Inhibition of protein kinase C prevents asbestos-induced c-fos and c-jun proto-oncogene expression in mesothelial cells","volume":"57","author":"Fung","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2008.08.014_bib58","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.str.2007.10.014","article-title":"Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor","volume":"15","author":"Eto","year":"2007","journal-title":"Structure"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208004601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208004601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T20:30:01Z","timestamp":1631910601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500208004601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0169500208004601"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2008.08.014","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}